Shoulder device under 10-Year watch
NCT ID NCT03423953
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 194 people who received the Comprehensive Nano shoulder device to replace their shoulder joint due to arthritis, bone death, or deformity. Researchers will track how long the implant lasts and how well patients can use their shoulder over 10 years. The goal is to gather real-world data on safety and performance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Comprehensive Nano shoulder device
What this could lead to
If successful, this could confirm the device's long-term safety and effectiveness for shoulder replacement.
What could go wrong
This is an observational post-market study, not a controlled trial, so results may not prove the device is better than alternatives. Risks include typical surgery complications like infection or implant failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chonnam National University Hospital
Gwangju, Gwangju, South Korea
-
Kingston General Hospital
Kingston, Ontario, K7L 3N6, Canada
-
Privatklinik Leech
Graz, Styria, 8010, Austria
-
Samsung Medical Centre
Seoul, Seoul, 06351, South Korea
-
University of Liverpool
Liverpool, Merseyside, L69 3BX, United Kingdom